Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2019;49(5):410-412.
doi: 10.1159/000499864. Epub 2019 Apr 12.

Treating Systemic Klotho Deficiency

Affiliations
Editorial

Treating Systemic Klotho Deficiency

Johanne Pastor et al. Am J Nephrol. 2019.
No abstract available

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
Existent methods to increase circulating Klotho levels. Recombinant Klotho protein can be given parentally to achieve adequate circulating levels. Klotho cDNA can be delivered. either as naked cDNA (full-length plasmid or minicircles) or encapsulated by adeno-associated virus. The majority of these reside in the liver and Klotho is released. The Klotho gene can be inserted into the genotype as a transgene with a strong promoter driving Klotho protein production. Finally, there are pharmacologic means to increase endogenous Klotho production. Statin: 3-hydroxy-3-methylglutaryl CoA reductase inhibitors. TZD or peroxisome proliferator-activated receptor-gamma agonists. The minicircle technology represents another version of Klotho cDNA. AAV, adeno-associated; PPAR-γ, peroxisome proliferator-activated receptor-gamma; ACEI, angiotensin-converting enzyme inhibitors; TZD, thiazolidinediones.

Comment on

References

    1. Kuro-o M, Matsumura Y, Aizawa H, Kawaguchi H, Suga T, Utsugi T, et al. Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature. 1997. November;390(6655):45–51. - PubMed
    1. Kurosu H, Yamamoto M, Clark JD, Pastor JV, Nandi A, Gurnani P, et al. Suppression of aging in mice by the hormone Klotho. Science. 2005. September;309(5742):1829–33. - PMC - PubMed
    1. Hu MC, Shiizaki K, Kuro-o M, Moe OW. Fibroblast growth factor 23 and Klotho: physiology and pathophysiology of an endocrine network of mineral metabolism. Annu Rev Physiol. 2013;75(1):503–33. - PMC - PubMed
    1. Neyra JA, Hu MC. Potential application of klotho in human chronic kidney disease. Bone. 2017. July;100:41–9. - PMC - PubMed
    1. Hu MC, Shi M, Gillings N, Flores B, Takahashi M, Kuro-O M, et al. Recombinant α-Klotho may be prophylactic and therapeutic for acute to chronic kidney disease progression and uremic cardiomyopathy. Kidney Int. 2017. May;91(5):1104–14. - PMC - PubMed